An evidence-based stroke prevention campaign in the Netherlands

Not Applicable

Completed

• Conditions: Improving awareness and prevention to reduce the burden of stroke in the general population in the Netherlands; Circulatory System; Stroke, not specified as haemorrhage or infarction

• Registration Number: ISRCTN10601888
• Lead Sponsor: Pfizer (Netherlands)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-02-17
• Study Completion: 2022-10-01
• Last Update Posted: 31 October 2022

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 2429

Inclusion Criteria

Aged 18 years and older

Exclusion Criteria

Does not meet the inclusion criteria

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<br> 1. Understanding the gaps in awareness related to lifestyle factors underlying the risk of stroke, and in relation to different personality traits. This is measured using a questionnaire (diagnostic survey) at baseline.<br> 2. Definition of the most effective health messaging strategy, tailored to personality traits, to increase awareness of stroke risk factors and to enhance self-detection of atrial fibrillation, measured using questionnaires before (at baseline) and after showing the different intervention videos.<br>

Secondary Outcome Measures

Name	Time	Method
<br> 1. Self-reported risk factors for stroke measured using questionnaires before (at baseline) and after showing the intervention video<br> 2. Identification of high-risk stroke participants and undetected atrial fibrillation in the research population using questionnaires before (at baseline) and after showing the intervention video<br>